The clinical relevance of this concept is underscored by regulatory validation: GFAP and UCH-L1 are components of the FDA-cleared Banyan Brain Trauma IndicatorTM for evaluating mild TBI in adults. This evidence concerns the gene UCHL1 and brain injury.